Found: 28
Select item for more details and to access through your institution.
CORRIGENDUM.
- Published in:
- 2019
- Publication type:
- Correction Notice
Cover Image, Volume 21, Issue 1.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1111/dom.13590
- Publication type:
- Article
News and Views.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
CORRIGENDUM.
- Published in:
- 2019
- Publication type:
- Correction Notice
Carbohydrate quantity in the dietary management of type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 15, doi. 10.1111/dom.13499
- By:
- Publication type:
- Article
Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 160, doi. 10.1111/dom.13498
- By:
- Publication type:
- Article
Cannabinoid‐1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 146, doi. 10.1111/dom.13497
- By:
- Publication type:
- Article
Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 136, doi. 10.1111/dom.13496
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case–control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 52, doi. 10.1111/dom.13480
- By:
- Publication type:
- Article
Impact on HbA1c and body weight of switching from other GLP‐1 receptor agonists to semaglutide: A model‐based approach.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 43, doi. 10.1111/dom.13479
- By:
- Publication type:
- Article
Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one‐year retrospective matched cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 37, doi. 10.1111/dom.13478
- By:
- Publication type:
- Article
Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 28, doi. 10.1111/dom.13477
- By:
- Publication type:
- Article
Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 129, doi. 10.1111/dom.13495
- By:
- Publication type:
- Article
A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 120, doi. 10.1111/dom.13494
- By:
- Publication type:
- Article
Risk of heart failure in a population with type 2 diabetes versus a population without diabetes with and without coronary heart disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 112, doi. 10.1111/dom.13493
- By:
- Publication type:
- Article
Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 3, doi. 10.1111/dom.13492
- By:
- Publication type:
- Article
Efficacy and safety of fixed‐dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double‐blind, controlled, phase 3 trial
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 103, doi. 10.1111/dom.13491
- By:
- Publication type:
- Article
Endogenous glucagon‐like peptide‐1 system response is impaired during ST‐elevation myocardial infarction in type 2 diabetes patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 194, doi. 10.1111/dom.13490
- By:
- Publication type:
- Article
Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 95, doi. 10.1111/dom.13489
- By:
- Publication type:
- Article
Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 84, doi. 10.1111/dom.13487
- By:
- Publication type:
- Article
Long‐term cost‐effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 73, doi. 10.1111/dom.13485
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 188, doi. 10.1111/dom.13484
- By:
- Publication type:
- Article
3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid (CMPF) prevents high fat diet‐induced insulin resistance via maintenance of hepatic lipid homeostasis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 61, doi. 10.1111/dom.13483
- By:
- Publication type:
- Article
Closed‐loop driven by control‐to‐range algorithm outperforms threshold‐low‐glucose‐suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 183, doi. 10.1111/dom.13482
- By:
- Publication type:
- Article
Elevated GlycA in severe obesity is normalized by bariatric surgery.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 178, doi. 10.1111/dom.13481
- By:
- Publication type:
- Article
Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 170, doi. 10.1111/dom.13475
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- 2019
- Publication type:
- Front Cover
Effectiveness and safety of empagliflozin‐based quadruple therapy compared with insulin glargine‐based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 173, doi. 10.1111/dom.13476
- By:
- Publication type:
- Article